As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  5/9/24  Larimar Therapeutics, Inc.        S-3                    7:2.5M                                   Donnelley … Solutions/FA 
  5/9/24  Larimar Therapeutics, Inc.        10-Q        3/31/24   48:6.1M                                   Donnelley … Solutions/FA 
  5/9/24  Larimar Therapeutics, Inc.        8-K:2,8,9    5/9/24   10:23M                                    Donnelley … Solutions/FA 
 4/29/24  Larimar Therapeutics, Inc.        ARS        12/31/23    1:10M                                    Donnelley … Solutions/FA 
 4/29/24  Larimar Therapeutics, Inc.        DEF 14A     5/29/24    1:2M                                     Donnelley … Solutions/FA 
 4/12/24  Larimar Therapeutics, Inc.        PRE 14A     5/29/24    1:2.1M                                   Donnelley … Solutions/FA 
 3/15/24  Flynn James E                     SC 13D/A               1:190K Larimar Therapeutics, Inc.        E-Data Systems, Inc./FA  
          Deerfield Healthcare Innovations Fund, L.P.³
          Deerfield Management Company, L.P.³
          Deerfield Mgmt Hif, L.P.³
          Deerfield Mgmt III, L.P.³
          Deerfield Mgmt, IV, L.P.³
          Deerfield Mgmt, L.P.³
          Deerfield Partners, L.P.³
          Deerfield Private Design Fund III, L.P.³
          Deerfield Private Design Fund IV, L.P.³
 3/14/24  Larimar Therapeutics, Inc.        S-8         3/14/24    4:75K                                    Donnelley … Solutions/FA 
 3/14/24  Larimar Therapeutics, Inc.        S-8         3/14/24    4:79K                                    Donnelley … Solutions/FA 
 3/14/24  Larimar Therapeutics, Inc.        10-K       12/31/23   63:10M                                    Donnelley … Solutions/FA 
 3/14/24  Larimar Therapeutics, Inc.        8-K:2,9     3/14/24    9:623K                                   Donnelley … Solutions/FA 
 3/11/24  Larimar Therapeutics, Inc.        8-K:8,9     3/11/24   11:33M                                    Donnelley … Solutions/FA 
 2/26/24  Ra Capital Management, L.P.       SC 13G                 1:88K  Larimar Therapeutics, Inc.        Toppan Merrill/FA        
          Peter Kolchinsky³
          Ra Capital Healthcare Fund, L.P³
          Rajeev Shah³
 2/16/24  Larimar Therapeutics, Inc.        8-K:1,9     2/14/24   12:453K                                   Donnelley … Solutions/FA 
 2/16/24  Deerfield Mgmt Co, LP (Series C)  4          D,%Own,Oth² 2:32K  Larimar Therapeutics, Inc.        E-Data Systems, Inc./FA  
          Deerfield Healthcare Innovations Fund, L.P.
          Deerfield Mgmt HIF, L.P.
          Deerfield Mgmt III, L.P.
          Deerfield Mgmt IV, L.P.
          Deerfield Mgmt L.P.
          Deerfield Partners, L.P.
          Deerfield Private Design Fund III, L.P.
          Deerfield Private Design Fund IV, L.P.
          Flynn James E
 2/16/24  Flynn James E                     SC 13D/A               1:201K Larimar Therapeutics, Inc.        E-Data Systems, Inc./FA  
          Deerfield Healthcare Innovations Fund, L.P.³
          Deerfield Management Company, L.P.³
          Deerfield Mgmt Hif, L.P.³
          Deerfield Mgmt III, L.P.³
          Deerfield Mgmt, IV, L.P.³
          Deerfield Mgmt, L.P.³
          Deerfield Partners, L.P.³
          Deerfield Private Design Fund III, L.P.³
          Deerfield Private Design Fund IV, L.P.³
 2/15/24  Flynn James E                     SC 13D/A               2:229K Larimar Therapeutics, Inc.        E-Data Systems, Inc./FA  
          Deerfield Healthcare Innovations Fund, L.P.³
          Deerfield Management Company, L.P.³
          Deerfield Mgmt Hif, L.P.³
          Deerfield Mgmt III, L.P.³
          Deerfield Mgmt, IV, L.P.³
          Deerfield Mgmt, L.P.³
          Deerfield Partners, L.P.³
          Deerfield Private Design Fund III, L.P.³
          Deerfield Private Design Fund IV, L.P.³
 2/15/24  Thomas Frank E                    4          Director²   1:4K   Larimar Therapeutics, Inc.        Newsfile Corp./FA        
 2/14/24‡ Blue Owl Capital Holdings LP      SC 13G      2/14/24    1:40K  Larimar Therapeutics, Inc.        Broadridge Fin’l So… Inc 
 2/14/24  Larimar Therapeutics, Inc.        424B5                  1:578K                                   Donnelley … Solutions/FA 

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:  -U
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	424B5	Prospectus – Primary Offering or Shelf Securities – New Facts or Events.
	ARS	Annual Report to Security Holders.
	DEF 14A	Definitive Proxy Statement — Schedule 14A.
	PRE 14A	Preliminary Proxy Statement — Schedule 14A.
	S-3	Registration Statement – Securities for a Transaction — Form S-3.
	S-8	Registration Statement – Securities for an Employee Benefit Plan — Form S-8.
	SC 13D	Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D.
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.
³	Group Member:  A Registrant or non-Registrant party to this Filing made by a Group.